Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine

Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group

C G Moertel, Stephen Frytak, R. G. Hahn et al. · Cancer · 1981 · 1K citations

Medicine, Oncology, Radiation Oncology +13

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

James L. Abbruzzese, Ralf Grunewald, Elizabeth A. Weeks et al. · Journal of Clinical Oncology · 1991 · 759 citations

Medicine, Oncology, Pharmacology +13

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer

Cancer · 1987 · 712 citations

Medicine, Oncology, Surgery +17

Variations in Several Responses of HeLa Cells to X-Irradiation during the Division Cycle

Toyozo Terasima, L. J. Tolmach · Biophysical Journal · 1963 · 592 citations

Life Sciences, Cancer Biology, Cell Biology +14

Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.

Volker Heinemann, Yi-Zheng Xu, Sherri Chubb et al. · Molecular Pharmacology · 1990 · 407 citations

Life Sciences, Biochemistry, Molecular Biology +13